{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:18:25Z","timestamp":1790957905310,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejmech.2021.113171","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T03:47:52Z","timestamp":1610509672000},"page":"113171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis"],"prefix":"10.1016","volume":"213","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3347-7449","authenticated-orcid":false,"given":"Zhaoxing","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaofeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfeng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincui","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1 Pt 1","key":"10.1016\/j.ejmech.2021.113171_bib1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0091-6749(99)70536-1","article-title":"Worldwide variations in the prevalence of symptoms of atopic eczema in the international study of asthma and allergies in childhood","volume":"103","author":"Williams","year":"1999","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113171_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.det.2017.02.006","article-title":"An update on the pathophysiology of atopic dermatitis","volume":"35","author":"Malik","year":"2017","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.ejmech.2021.113171_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","article-title":"Atopic dermatitis: pathophysiology","volume":"1027","author":"David Boothe","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113171_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1203475416685077","article-title":"Review of atopic dermatitis and topical therapies","volume":"21","author":"Mayba","year":"2017","journal-title":"J.\u00a0Cutan. Med. Surg."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113171_bib5","first-page":"171","article-title":"High-dose caspofungin as a component of combination antifungal therapy in 91 patients with neoplastic diseases and hematopoietic stem cell transplantation: a critical review of short-term and long-term adverse events","volume":"28","author":"Amar","year":"2015","journal-title":"J.\u00a0Pharm. Pract."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113171_bib6","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","article-title":"The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis","volume":"19","author":"Dainichi","year":"2018","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113171_bib7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/DER.0000000000000340","article-title":"Immune dysregulation in the pathogenesis of atopic dermatitis","volume":"29","author":"Gavrilova","year":"2018","journal-title":"Dermatitis"},{"issue":"12","key":"10.1016\/j.ejmech.2021.113171_bib8","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.bpj.2017.04.045","article-title":"Channeling of cAMP in PDE-PKA complexes promotes signal adaptation","volume":"112","author":"Tulsian","year":"2017","journal-title":"Biophys. J."},{"issue":"30","key":"10.1016\/j.ejmech.2021.113171_bib9","doi-asserted-by":"crossref","first-page":"E6240","DOI":"10.1073\/pnas.1703939114","article-title":"Analyses of PDE-regulated phosphoproteomes reveal unique and specific cAMP-signaling modules in T cells","volume":"114","author":"Beltejar","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"28","key":"10.1016\/j.ejmech.2021.113171_bib10","first-page":"3054","article-title":"Phosphodiesterase 4 inhibitors in immune-mediated diseases: mode of action, clinical applications, current and future perspectives","volume":"24","author":"Lazaros","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113171_bib11","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ejmech.2018.03.046","article-title":"Inhibitors of phosphodiesterase as cancer therapeutics","volume":"150","author":"Ting","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113171_bib12","first-page":"4","article-title":"Crisaborole 2% ointment (eucrisa) for atopic dermatitis","volume":"24","author":"Woo","year":"2019","journal-title":"Skin Therapy Lett"},{"issue":"4","key":"10.1016\/j.ejmech.2021.113171_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/pde.12872","article-title":"Crisaborole topical ointment, 2% in patients ages 2 to 17 years with atopic dermatitis: a phase 1b, open-label, maximal-use systemic exposure study","volume":"33","author":"Zane","year":"2016","journal-title":"Pediatr. Dermatol."},{"issue":"8","key":"10.1016\/j.ejmech.2021.113171_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.2217\/imt-2016-0023","article-title":"Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies","volume":"8","author":"Zane","year":"2016","journal-title":"Immunotherapy"},{"issue":"19","key":"10.1016\/j.ejmech.2021.113171_bib15","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.1016\/j.febslet.2012.07.058","article-title":"Boron-based phosphodiesterase inhibitors show novel binding of boron to PDE4 bimetal center","volume":"586","author":"Freund","year":"2012","journal-title":"FEBS Lett."},{"issue":"32","key":"10.1016\/j.ejmech.2021.113171_bib16","first-page":"1575","article-title":"anti-HIV Agents. Part 55. 3\u2032R, 4\u2032R-Di-(O)-(-)-camphanoyl-2\u2032,2\u2032-dimethyldihydropyrano [2,3-f]chromone (DCP), a Novel anti-HIV Agent","volume":"34","author":"Donglei","year":"2003","journal-title":"ChemInform"},{"key":"10.1016\/j.ejmech.2021.113171_bib17","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1016\/j.tet.2013.01.001","article-title":"Norman Nicolaus, Mark Lautens Domino CeH functionalization reactions of gem-dibromoolefins: synthesis of N-fused benzo[c]carbazoles","volume":"69","author":"Huang","year":"2013","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113171_bib18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejmech.2013.09.024","article-title":"Multifunctional tacrine flavonoid hybrids with cholinergic, b-amyloid- reducing, and metal chelating properties for the treatment of Alzheimer\u2019s disease","volume":"69","author":"Su","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmech.2021.113171_bib19","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1021\/ol701552r","article-title":"Chemoenzymatic approaches to lycorine-type Amaryllidaceae alkaloids: total syntheses of ent-lycoricidine, 3-epi-ent-Lycoricidine, and 4-Deoxy-3-epient -lycoricidine","volume":"9","author":"Matveenko","year":"2007","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2021.113171_bib20","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1016\/j.tet.2004.08.056","article-title":"Fahrni Fluorescence sensing based on cation-induced conformational switching: copper-selective modulation of the photoinduced intramolecular charge transfer of a donor\u2013acceptor biphenyl fluorophore","volume":"60","author":"John","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.113171_bib21","first-page":"204","article-title":"Synthesis, characterization, crystal structure and cytotoxicities of 2-aroyl-3- aryl-5H-furo[3,2-g] chromene derivatives","volume":"11","author":"Shi-Hui","year":"2010","journal-title":"ARKIVOC"},{"issue":"37","key":"10.1016\/j.ejmech.2021.113171_bib22","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1016\/S0040-4039(01)01302-8","article-title":"A\u00a0convenient access to benzo-substituted phthalazines as potential precursors to DNA intercalators","volume":"42","author":"Tsoungas","year":"2001","journal-title":"Tetrahedron Lett."},{"issue":"07","key":"10.1016\/j.ejmech.2021.113171_bib23","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1055\/s-0035-1561265","article-title":"Regioselective suzuki-miyaura reactions of the bis(triflate) of 6,7-Dihydroxy-2,2-dimethyl- chroman-4-one","volume":"27","author":"Pajt\u00e1s","year":"2016","journal-title":"Synlett"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113171_bib24","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/jhet.5570250333","article-title":"A\u00a0novel synthesis of precocenes. Efficient synthesis and regioselective O-alkylation of dihydroxy-2,2-dimethyl-4- chromanones","volume":"25","author":"Tibor","year":"1988","journal-title":"J.\u00a0Heterocycl. Chem."},{"key":"10.1016\/j.ejmech.2021.113171_bib25","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1021\/jo016196i","article-title":"Novel synthesis of 2-chloroquinolines from 2-vinylanilines in nitrile solvent","volume":"67","author":"Byoung","year":"2002","journal-title":"J.\u00a0Org. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113171_bib26","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1021\/jm040873u","article-title":"2-(4-Alkylpiperazin-1-yl) quinolines as a New class of imidazole-free histamine H3 receptor antagonists","volume":"48","author":"Zaragoza","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"issue":"37","key":"10.1016\/j.ejmech.2021.113171_bib27","doi-asserted-by":"crossref","first-page":"13068","DOI":"10.1002\/chem.201603105","article-title":"Palladium-catalyzed asymmetric arylation of trifluoromethylated\/perfluoroalkylated 2-quinazolinones with high enantioselectivity","volume":"22","author":"Zhou","year":"2016","journal-title":"Chemistry"},{"issue":"12","key":"10.1016\/j.ejmech.2021.113171_bib28","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1016\/j.jid.2018.06.168","article-title":"Eosinophils determine dermal thickening and water loss in a MC903 model of atopic dermatitis","volume":"38","author":"Naidoo","year":"2018","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2021.113171_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-6786-5_8","article-title":"A\u00a0mouse model for atopic dermatitis using topical application of vitamin D3 or of its analog MC903","volume":"1559","author":"Moosbruggermartinz","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113171_bib30","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/toxsci\/kft215","article-title":"The atopic dermatitis-like symptoms induced by MC903 were alleviated in JNK1 knockout mice","volume":"136","author":"Choi","year":"2013","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2021.113171_bib31","doi-asserted-by":"crossref","first-page":"105676","DOI":"10.1016\/j.intimp.2019.105676","article-title":"Anti-inflammatory effects of quercetin in a mouse model of MC903-induced atopic dermatitis","volume":"74","author":"Hou","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejmech.2021.113171_bib32","first-page":"46","article-title":"The abdominal skin of female Sprague-Dawley rats is more sensitive than the back skin to drug-induced phototoxicity","author":"Kazuhiro","year":"2017","journal-title":"J.\u00a0Pharmacol. Toxicol. Methods"},{"issue":"2","key":"10.1016\/j.ejmech.2021.113171_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/1570163815666181017091655","article-title":"Docking studies of curcumin and analogues with various phosphodiesterase 4 subtypes","volume":"17","author":"Yi","year":"2020","journal-title":"Curr. Drug Discov. Technol."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113171_bib34","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.4103\/0366-6999.183427","article-title":"Topical tetracycline improves MC903-induced atopic dermatitis in mice through inhibition of inflammatory cytokines and thymic stromal lymphopoietin expression","volume":"129","author":"Liu","year":"2016","journal-title":"Chin. Med. J."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421000209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421000209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:20:26Z","timestamp":1759328426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421000209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":34,"alternative-id":["S0223523421000209"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113171","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113171"}}